The 1 Hour Fasting and Postprandial Glucose test is a two-part diagnostic evaluation that first measures the glucose level in the blood after an overnight fast and then assesses it again one hour after consuming a glucose-rich meal or drink.

The Postprandial Glucose Tolerance Test, 1-Hour evaluates blood glucose response one hour after eating or consuming a glucose solution. This test is commonly used to detect abnormal post-meal glucose regulation, prediabetes, and diabetes risk. Measuring the body’s ability to manage glucose following food intake offers important data on insulin function, carbohydrate handling, and metabolic balance.

The Postprandial Glucose Tolerance Test, 2-Hour evaluates glucose response two hours after eating or consuming a glucose solution. It is an important diagnostic tool for detecting abnormal post-meal glucose regulation, prediabetes, and diabetes risk. Measuring the body’s glucose clearance at this critical interval highlights insulin function, carbohydrate handling, and early metabolic dysfunction.

 The 2 Hour Fasting and Postprandial Glucose Test is a diagnostic procedure that measures the body's ability to metabolize glucose (sugar) and respond to insulin. It involves taking two blood samples: one after an overnight fast and another two hours after consuming a meal.

The Insulin Response to Glucose Test, 3 Specimens evaluates insulin secretion at three time points: fasting and after drinking a glucose solution at set intervals. This approach helps identify abnormal insulin sensitivity, altered beta-cell activity, and impaired carbohydrate metabolism. Results provide essential information about how efficiently the body regulates glucose, supporting early detection of insulin resistance or diabetes risk.

The C-Peptide Response to Glucose Test with 5 specimens measures pancreatic beta cell activity and insulin secretion across five timed intervals. Tracking C-peptide levels over multiple points provides detailed insight into glucose regulation, insulin resistance, hypoglycemia, and diabetes risk, supporting evaluation of metabolic balance and overall endocrine health.

The 1,5-Anhydroglucitol Intermediate Glycemic Control Test measures short- to mid-term blood sugar stability, offering an advanced indicator of daily glucose control and metabolic health. It bridges the gap between fasting glucose and HbA1c results, helping identify hidden glucose spikes that affect insulin function, diabetes management, and long-term health outcomes.

The Fructosamine Test measures average blood glucose levels over the past 2–3 weeks by evaluating glycated proteins. Unlike the HbA1c test, which reflects long-term control, this test provides a shorter-term view, making it useful for monitoring recent treatment changes, pregnancy, or conditions affecting red blood cells. Doctors use it to assess diabetes management, adjust medications, and evaluate how well blood sugar is being controlled.

The Hemoglobin A1c with Calculated Mean Plasma Glucose Test measures average blood sugar over 2–3 months and provides an estimated mean plasma glucose (eAG). Elevated A1c may indicate diabetes or poor glucose control, while normal results reflect healthy management. Doctors use this test to diagnose diabetes, assess long-term control, and adjust treatment. Results give valuable insight into glycemic control, reducing risk of complications like kidney, eye, and heart disease.

 The Hemoglobin A1c and Glucose panel is a combination of two essential blood tests that provide valuable information about an individual's blood sugar levels over both short and extended periods. This panel helps healthcare professionals assess how well a person's blood sugar is being managed and can indicate the risk or presence of diabetes.

The C-Peptide Test measures C-peptide levels in blood to assess insulin production and pancreatic function. Low levels may indicate type 1 diabetes or reduced insulin production, while high levels may suggest type 2 diabetes, insulin resistance, or insulinoma. Doctors use this test to differentiate diabetes types, monitor treatment, and evaluate unexplained hypoglycemia. It provides key insight into endocrine, pancreatic, and metabolic health.